相关实验视频
Updated: Jun 17, 2025

10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.3K
基氨酸细胞癌中的微RNA失调:临床证据,功能影响和未来方向
Jessica Conley1, Benjamin Genenger1, Bruce Ashford2,3
1Molecular Horizons, School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2500, Australia.
International journal of molecular sciences
|August 10, 2024
概括
微RNAs (miRNAs) 在状细胞癌 (KC) 的发展中发挥作用. 需要结合临床和实验数据的更一致的研究,以了解它们的功能和作为基底细胞癌 (BCC) 和皮肤状细胞癌 (cSCC) 的生物标志物的使用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 皮肤病学 皮肤病学
背景情况:
- 状细胞癌,包括基底细胞癌 (BCC) 和皮肤状细胞癌 (cSCC),是人类最常见的癌症.
- 微RNAs (miRNAs) 越来越多地被研究为其在KC病变发生,进展中的作用,以及作为潜在的治疗点或生物标志物.
- 目前的文献显示了关于特定miRNA参与BCC和cSCC生物学方面的不一致性.
研究的目的:
- 审查和评估miRNA调节失调在KCs.临床证据的质量.
- 确定研究缺口,并为未来的研究提供建议.
- 探索miRNAs在KC细胞生物学中的功能影响及其作为生物标记物的潜力.
主要方法:
- 对人类cSCC和BCC中miRNA失调的临床证据的系统审查.
- 对miRNA研究的验证质量的评估.
- 对研究miRNA目标和功能影响的研究进行分析.
- 探索miRNA在瘤微环境中的作用和临床实用性.
主要成果:
- 在文献中,关于cSCC和BCC中的特定miRNA存在重大不一致.
- 结合的临床和实验miRNA研究提供了比孤立方法更强有力的证据.
- miRNA失调可以推动瘤细胞生物学中的大规模变化.
- miRNAs参与调节各种细胞功能.
结论:
- 需要更一致,更高质量的研究,将临床数据与KCs中miRNA功能的实验验证相结合.
- 进一步研究miRNAs作为瘤微环境中的细胞间通讯器是有必要的.
- miRNAs作为基氨酸细胞癌预后和治疗的生物标志物具有前景,但需要进一步验证.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
Epigenetic Regulation
31.0K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.0K

